| EGFR signaling and drug discovery G Lurje, HJ Lenz Oncology 77 (6), 400-410, 2009 | 592 | 2009 |
| FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent … W Zhang, M Gordon, AM Schultheis, DY Yang, F Nagashima, M Azuma, ... Journal of Clinical Oncology 25 (24), 3712-3718, 2007 | 577 | 2007 |
| Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models Y Ning, PC Manegold, YK Hong, W Zhang, A Pohl, G Lurje, T Winder, ... International journal of cancer 128 (9), 2038-2049, 2011 | 539 | 2011 |
| A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer RK Ramanathan, CP Belani, DA Singh, M Tanaka, HJ Lenz, Y Yen, ... Cancer chemotherapy and pharmacology 64 (4), 777-783, 2009 | 349 | 2009 |
| Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity D Yang, A Hendifar, C Lenz, K Togawa, F Lenz, G Lurje, A Pohl, T Winder, ... Journal of Gastrointestinal Oncology 2 (2), 77, 2011 | 268 | 2011 |
| Gender disparities in metastatic colorectal cancer survival A Hendifar, D Yang, F Lenz, G Lurje, A Pohl, C Lenz, Y Ning, W Zhang, ... Clinical Cancer Research 15 (20), 6391-6397, 2009 | 247 | 2009 |
| Treatment strategies for hepatocellular carcinoma—a multidisciplinary approach I Lurje, Z Czigany, J Bednarsch, C Roderburg, P Isfort, UP Neumann, ... International journal of molecular sciences 20 (6), 1465, 2019 | 244 | 2019 |
| Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab AM Schultheis, G Lurje, KE Rhodes, W Zhang, D Yang, AA Garcia, ... Clinical Cancer Research 14 (22), 7554-7563, 2008 | 214 | 2008 |
| Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation … Z Czigany, J Pratschke, J Froněk, M Guba, W Schöning, DA Raptis, ... Annals of surgery 274 (5), 705-712, 2021 | 198 | 2021 |
| Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent JM Leers, C Vivaldi, H Schäfer, M Bludau, J Brabender, G Lurje, ... Surgical endoscopy 23 (10), 2258-2262, 2009 | 178 | 2009 |
| A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with … W Zhang, T Winder, Y Ning, A Pohl, D Yang, M Kahn, G Lurje, MJ Labonte, ... Annals of Oncology 22 (1), 104-109, 2011 | 177 | 2011 |
| Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer G Lurje, W Zhang, AM Schultheis, D Yang, S Groshen, AE Hendifar, ... Annals of Oncology 19 (10), 1734-1741, 2008 | 167 | 2008 |
| Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity M Linecker, B Björnsson, GA Stavrou, KJ Oldhafer, G Lurje, U Neumann, ... Annals of surgery 266 (5), 779-786, 2017 | 158 | 2017 |
| Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer … G Lurje, F Nagashima, W Zhang, D Yang, HM Chang, MA Gordon, ... Clinical Cancer Research 14 (23), 7884-7895, 2008 | 135 | 2008 |
| The ALPPS risk score: avoiding futile use of ALPPS M Linecker, GA Stavrou, KJ Oldhafer, RM Jenner, B Seifert, G Lurje, ... Annals of surgery 264 (5), 763-771, 2016 | 134 | 2016 |
| Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy E Schadde, M Malagó, R Hernandez-Alejandro, J Li, E Abdalla, V Ardiles, ... Surgery 157 (4), 676-689, 2015 | 114 | 2015 |
| Ischemia-reperfusion injury in marginal liver grafts and the role of hypothermic machine perfusion: molecular mechanisms and clinical implications Z Czigany, I Lurje, M Schmelzle, W Schöning, R Öllinger, N Raschzok, ... Journal of Clinical Medicine 9 (3), 846, 2020 | 106 | 2020 |
| Machine perfusion for liver transplantation in the era of marginal organs—new kids on the block Z Czigany, I Lurje, RH Tolba, UP Neumann, F Tacke, G Lurje Liver International 39 (2), 228-249, 2019 | 105 | 2019 |
| Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation Z Czigany, W Kramp, J Bednarsch, G van der Kroft, J Boecker, P Strnad, ... American Journal of Transplantation 20 (2), 493-503, 2020 | 98 | 2020 |
| Thymidylate synthase gene variations: predictive and prognostic markers G Lurje, PC Manegold, Y Ning, A Pohl, W Zhang, HJ Lenz Molecular cancer therapeutics 8 (5), 1000-1007, 2009 | 98 | 2009 |
Frank TackeProfessor of Medicine, Charité University Medicine BerlinBestätigte E-Mail-Adresse bei charite.de